Cantor Fitzgerald Has Weak Forecast for PACB FY2025 Earnings
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) – Analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for Pacific Biosciences of California in a note issued to investors on Tuesday, February 18th. Cantor Fitzgerald analyst R. Osborn now expects that the biotechnology company will post earnings of ($0.68) per share for the year, […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) – Analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for Pacific Biosciences of California in a note issued to investors on Tuesday, February 18th. Cantor Fitzgerald analyst R. Osborn now expects that the biotechnology company will post earnings of ($0.68) per share for the year, […]
